Praxis Precision Medicines grants 3,478 inducement RSUs to 14 new employees under 2024 plan

By Public Technologies
  • Praxis Precision Medicines granted restricted stock units covering 3,478 common shares to 14 new non-executive employees on Oct. 1, 2026.
  • Awards were issued under the company’s 2024 Inducement Plan.
  • Restricted stock units vest in four equal annual installments, contingent on continued employment at each vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Praxis Precision Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021601PRIMZONEFULLFEED9838743) on October 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.